three of which target tumor necrosis factor (TNF). When considering the impact of biologic therapy on the management of IBD, it is important to consider the positioning of the biologic agents as ...

Per os; sc.: Subcutaneous injection; UC: Ulcerative colitis. Numerous biological agents are currently available for the treatment of patients with inflammatory bowel disease (IBD). These agents ...

Such risk stratification in individual patients with IBD may help identify when a 'top down' approach with early biologic therapy is justified. In this article, the authors will review both the ...